JYNT - Joint Corp-The Stock Price, Fair Value and News

17.28USD-0.38 (-2.15%)Market Closed

Market Summary

USD17.28-0.38

Market Closed

-2.15%

JYNT Stock Price

View Fullscreen

JYNT RSI Chart

JYNT Valuation

Market Cap

258.7M

Price/Earnings (Trailing)

-23.25

Price/Sales (Trailing)

2.2

EV/EBITDA

31.71

Price/Free Cashflow

35.59

JYNT Price/Sales (Trailing)

JYNT Profitability

Operating Margin

90.83%

EBT Margin

-0.34%

Return on Equity

-42.48%

Return on Assets

-12.99%

Free Cashflow Yield

2.81%

JYNT Fundamentals

JYNT Revenue

Revenue (TTM)

117.7M

Rev. Growth (Yr)

4.47%

Rev. Growth (Qtr)

2.19%

JYNT Earnings

Earnings (TTM)

-11.1M

Earnings Growth (Yr)

-59.29%

Earnings Growth (Qtr)

108.58%

Breaking Down JYNT Revenue

Last 7 days

5.1%

Last 30 days

43.8%

Last 90 days

66.0%

Trailing 12 Months

12.1%

How does JYNT drawdown profile look like?

JYNT Financial Health

Current Ratio

1.34

JYNT Investor Care

Shares Dilution (1Y)

2.01%

Diluted EPS (TTM)

-0.75

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	107.5M	0	0	117.7M
2022	84.9M	89.8M	95.5M	101.3M
2021	62.4M	69.8M	75.2M	80.0M
2020	51.4M	52.8M	55.5M	58.7M
2019	38.7M	41.1M	44.5M	48.5M
2018	28.0M	30.8M	33.5M	36.7M
2017	21.9M	23.0M	24.0M	25.0M
2016	15.6M	17.1M	18.5M	20.5M
2015	8.1M	9.8M	12.1M	13.8M
2014	6.2M	6.5M	6.8M	7.1M
2013	0	0	0	6.0M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Joint Corp-The

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 21, 2023	bandera partners llc	bought	2,092,100	9.59233	218,101	-
Sep 20, 2023	bandera partners llc	bought	215,165	9.49284	22,666	-
Sep 19, 2023	bandera partners llc	bought	893	9.4	95.00	-
Sep 18, 2023	bandera partners llc	bought	225,954	9.43006	23,961	-
Sep 15, 2023	bandera partners llc	bought	69,859	9.4686	7,378	-
Sep 14, 2023	bandera partners llc	bought	420,801	9.1286	46,097	-
Sep 13, 2023	bandera partners llc	bought	240,102	9.28219	25,867	-
Sep 12, 2023	bandera partners llc	bought	123,570	9.49591	13,013	-
Sep 11, 2023	bandera partners llc	bought	78,007	9.4257	8,276	-
Sep 07, 2023	bandera partners llc	bought	194,120	9.1106	21,307	-

Which funds bought or sold JYNT recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-38.91	-3,824	18,702	-%
May 16, 2024	Ancora Advisors LLC	added	105	830,614	1,295,710	0.03%
May 16, 2024	JANE STREET GROUP, LLC	sold off	-100	-250,648	-	-%
May 16, 2024	Grandeur Peak Global Advisors, LLC	reduced	-60.97	-348,624	393,720	0.03%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	12.56	350,316	1,011,630	-%
May 15, 2024	AQR CAPITAL MANAGEMENT LLC	reduced	-79.6	-501,815	192,517	-%
May 15, 2024	D. E. Shaw & Co., Inc.	reduced	-15.07	504,849	3,780,000	-%
May 15, 2024	JANUS HENDERSON GROUP PLC	reduced	-4.00	133,646	572,419	-%
May 15, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	sold off	-100	-142,228	-	-%
May 15, 2024	TWO SIGMA INVESTMENTS, LP	sold off	-100	-143,948	-	-%

Are Funds Buying or Selling JYNT?

Are funds buying JYNT calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own JYNT

No. of Funds

Unveiling Joint Corp-The's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	6.99%	1,031,068	SC 13G/A
Jan 26, 2024	blackrock inc.	6.8%	1,004,619	SC 13G/A
Jan 12, 2024	millennium management llc	0.5%	68,815	SC 13G/A
Nov 08, 2023	bandera partners llc	26.7%	3,937,296	SC 13D/A
Sep 25, 2023	bandera partners llc	26.7%	3,937,296	SC 13D/A
Sep 15, 2023	bandera partners llc	24.9%	3,672,473	SC 13D/A
Aug 11, 2023	bandera partners llc	23.6%	3,466,560	SC 13D
Mar 08, 2023	blackrock inc.	6.8%	992,289	SC 13G/A
Feb 13, 2023	bandera partners llc	17.4%	2,529,748	SC 13G/A
Feb 09, 2023	blackrock inc.	6.5%	941,786	SC 13G/A

Recent SEC filings of Joint Corp-The

View All Filings

Date Filed	Form Type	Document
May 13, 2024	DEFA14A	DEFA14A
May 03, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 19, 2024	DEF 14A	DEF 14A
Mar 08, 2024	10-K	Annual Report
Mar 07, 2024	8-K	Current Report
Feb 13, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Joint Corp-The)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Joint Corp-The News

Latest updates

Joint Corp-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	2.2%	29,722	29,086	28,450	27,678	26,450	24,887	22,237	21,895	20,782	20,004	17,330	17,038	15,411	12,590	13,644	13,875	12,726	11,170	10,679	9,968	9,242
Cost Of Revenue	-5.4%	2,716	2,872	2,475	2,466	2,337	2,257	2,111	2,203	2,090	1,824	1,547	1,941	1,712	1,368	1,486	1,634	1,427	1,299	1,206	1,202	1,085
S&GA Expenses	-3.1%	25,554	26,372	26,414	23,697	23,116	23,872	20,158	19,143	16,825	15,659	14,568	12,320	11,993	11,018	11,404	10,901	10,629	9,401	8,425	8,229	8,061
EBITDA Margin	-27.5%	0.06*	0.09*	0.11*	0.07*	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-	19.00	-	82.00	-	-	-	-	-	-	-	36.00	-	-	-	-	-	-	-	-	-	-
Income Taxes	-98.4%	179	10,898	842	629	-24.01	-477	-59.08	27.00	-389	-535	-610	-7,882	76.00	118	-65.93	32.00	7.00	10.00	1.00	70.00	-50.17
Earnings Before Taxes	882.2%	1,126	-143	3,168	1,393	707	-1,349	-54.86	523	1,854	2,550	1,129	2,751	1,680	233	749	1,325	624	472	951	507	-257
EBT Margin	-124.6%	0.00*	0.01*	0.04*	0.01*	0.00*	0.01*	0.06*	0.08*	0.11*	0.12*	-	-	-	-	-	-	-	-	-	-	-
Net Income	108.6%	947	-11,041	2,326	763	731	-871	4.00	497	2,244	3,085	1,739	10,633	1,604	116	815	1,292	617	462	953	437	-207
Net Income Margin	-14.1%	-0.09*	-0.08*	0.03*	0.01*	0.00*	0.02*	0.07*	0.09*	0.24*	0.24*	-	-	-	-	-	-	-	-	-	-	-
Free Cashflow	8.9%	2,415	2,217	4,824	3,601	3,060	-3,257	-1,092	1,175	1,293	4,456	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.7%	86.00	87.00	99.00	99.00	100	93.00	89.00	87.00	87.00	87.00	82.00	78.00	67.00	66.00	52.00	50.00	46.00	44.00	42.00	36.00	34.00
Current Assets	0.7%	45.00	44.00	28.00	23.00	24.00	18.00	19.00	18.00	26.00	27.00	25.00	24.00	23.00	25.00	22.00	19.00	15.00	13.00	11.00	12.00	11.00
Cash Equivalents	8.3%	20.00	18.00	16.00	14.00	15.00	10.00	10.00	9.00	18.00	20.00	20.00	19.00	18.00	21.00	18.00	15.00	11.00	9.00	8.00	9.00	8.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.00	8.00	8.00	8.00	7.00	6.00	5.00	4.00
Goodwill	-1.7%	7.00	7.00	8.00	8.00	8.00	8.00	8.00	8.00	5.00	5.00	5.00	5.00	0.00	5.00	4.00	4.00	4.00	4.00	4.00	3.00	3.00
Liabilities	-4.7%	59.00	62.00	63.00	64.00	64.00	61.00	58.00	57.00	56.00	57.00	52.00	52.00	44.00	45.00	43.00	42.00	39.00	38.00	38.00	34.00	32.00
Current Liabilities	-0.7%	33.00	34.00	28.00	25.00	25.00	23.00	22.00	20.00	21.00	21.00	21.00	22.00	17.00	18.00	16.00	15.00	13.00	14.00	13.00	12.00	11.00
Shareholder's Equity	5.9%	26.00	25.00	35.00	35.00	35.00	33.00	31.00	30.00	31.00	30.00	30.00	27.00	23.00	21.00	9.00	7.00	7.00	6.00	4.00	3.00	2.00
Retained Earnings	4.3%	-20.96	-21.91	-10.86	-10.15	-9.83	-12.15	-12.92	-13.65	-12.78	-12.78	-13.30	-15.52	-18.61	-20.09	-31.10	-32.71	-32.82	-33.64	-35.35	-35.97	-36.43
Additional Paid-In Capital	1.0%	48.00	47.00	47.00	46.00	46.00	46.00	45.00	45.00	44.00	44.00	44.00	43.00	42.00	41.00	41.00	40.00	40.00	39.00	39.00	39.00	39.00
Shares Outstanding	1.2%	15.00	15.00	15.00	15.00	15.00	15.00	15.00	14.00	14.00	14.00	14.00	14.00	-	-	-	-	-	-	-	-	-
Minority Interest	0%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	100*	100*	100*	100*	100*	100*	100*	100*	100*	-100*
Float	-	-	-	-	124	-	-	-	137	-	-	-	880	-	-	-	206	-	-	-	236	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-16.9%	2,810	3,383	3,802	1,469	6,025	5,177	4,217	-1,382	198	2,781	3,437	6,743	883	4,276	3,871	1,565	1,472	2,817	1,868	2,377	460
Share Based Compensation	0.5%	493	491	526	417	266	330	306	340	324	229	297	284	246	207	212	216	250	184	186	179	172
Cashflow From Investing	73.6%	-344	-1,304	-1,103	-2,579	-1,200	-5,611	-3,523	-7,475	-1,289	-2,878	-2,386	-6,537	-951	-2,375	-320	-684	-1,221	-1,182	-3,749	-1,004	-1,201
Cashflow From Financing	-32333.7%	-2,012	-6.21	-7.33	58.00	130	16.00	239	47.00	26.00	18.00	108	621	-2,743	473	87.00	2,959	2,077	-988	262	44.00	85.00
Buy Backs	656100.0%	7.00	1*	1.00	-	3.00	-	3.00	-	3.00	-1*	90.00	-	618	28.00	488*	-	4.00	1*	20.00	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

JYNT Income Statement

2024-03-31

Condensed Consolidated Income Statements (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 29,722,166	$ 28,300,820
Cost of revenues:
Total cost of revenues	2,716,076	2,474,685
Selling and marketing expenses	3,886,113	4,160,244
Depreciation and amortization	1,403,906	2,215,055
General and administrative expenses	20,263,692	20,038,476
Total selling, general and administrative expenses	25,553,711	26,413,775
Net loss on disposition or impairment	362,103
Income (loss) from operations	1,090,276	(653,109)
Other income, net	35,630	3,821,162
Income before income tax expense	1,125,906	3,168,053
Income tax expense	178,927	841,889
Net income	$ 946,979	$ 2,326,164
Earnings per share:
Basic earnings per share (in dollars per share)	$ 0.06	$ 0.16
Diluted earnings per share (in dollars per share)	$ 0.06	$ 0.16
Basic weighted average shares (in shares)	14,801,354	14,566,185
Diluted weighted average shares (in shares)	15,011,286	14,861,734
Revenues from company-owned or managed clinics
Revenues:
Total revenues	$ 17,537,504	$ 17,127,957
Royalty fees
Revenues:
Total revenues	7,587,547	6,866,023
Franchise fees
Revenues:
Total revenues	655,873	754,425
Cost of revenues:
Cost of revenues	2,341,765	2,140,835
Advertising fund revenue
Revenues:
Total revenues	2,166,473	1,952,406
Software fees
Revenues:
Total revenues	1,386,776	1,210,005
Cost of revenues:
Cost of revenues	374,311	333,850
Other revenues
Revenues:
Total revenues	$ 387,993	$ 390,004

JYNT Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 18,742,884	$ 18,153,609
Restricted cash	923,958	1,060,683
Accounts receivable, net	3,265,800	3,718,924
Deferred franchise and regional development costs, current portion	1,046,156	1,047,430
Prepaid expenses and other current assets	2,926,719	2,439,837
Assets held for sale	17,726,238	17,915,055
Total current assets	44,631,755	44,335,538
Property and equipment, net	10,303,746	11,044,317
Operating lease right-of-use asset	12,214,619	12,413,221
Deferred franchise and regional development costs, net of current portion	5,016,644	5,203,936
Intangible assets, net	4,573,725	5,020,926
Goodwill	7,226,701	7,352,879
Deferred tax assets ($1.1 million and $1.1 million attributable to VIEs as of March 31, 2024 and December 31, 2023)	960,621	1,031,648
Deposits and other assets	755,743	748,394
Total assets	85,683,554	87,150,859
Current liabilities:
Accounts payable	1,281,198	1,625,088
Accrued expenses	1,964,005	1,963,009
Co-op funds liability	923,958	1,060,683
Payroll liabilities ($1.0 million and $0.7 million attributable to VIEs as of March 31, 2024 and December 31, 2023)	4,511,015	3,485,744
Operating lease liability, current portion	3,750,477	3,756,328
Finance lease liability, current portion	25,763	25,491
Deferred franchise fee revenue, current portion	2,528,468	2,516,554
Deferred revenue from company clinics ($1.6 million and $1.6 million attributable to VIEs as of March 31, 2024 and December 31, 2023)	4,603,602	4,463,747
Upfront regional developer fees, current portion	340,040	362,326
Other current liabilities	585,110	483,249
Liabilities to be disposed of ($3.7 million and $3.6 million attributable to VIEs as of March 31, 2024 and December 31, 2023)	12,832,986	13,831,863
Total current liabilities	33,346,622	33,574,082
Operating lease liability, net of current portion	10,606,889	10,914,997
Finance lease liability, net of current portion	31,471	38,016
Debt under the Credit Agreement	0	2,000,000
Deferred franchise fee revenue, net of current portion	13,316,975	13,597,325
Upfront regional developer fees, net of current portion	940,662	1,019,316
Other liabilities ($1.2 million and $1.2 million attributable to VIE as of March 31, 2024 and December 31, 2023)	1,235,241	1,235,241
Total liabilities	59,477,860	62,378,977
Commitments and contingencies (Note 10)
Stockholders' equity:
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of March 31, 2024 and December 31, 2023	0	0
Common stock, $0.001 par value; 20,000,000 shares authorized, 14,968,547 shares issued and 14,935,716 shares outstanding as of March 31, 2024 and 14,783,757 shares issued and 14,751,633 outstanding as of December 31, 2023	14,967	14,783
Additional paid-in capital	47,991,362	47,498,151
Treasury stock 32,831 shares as of March 31, 2024 and 32,124 shares as of December 31, 2023, at cost	(867,037)	(860,475)
Accumulated deficit	(20,958,598)	(21,905,577)
Total The Joint Corp. stockholders' equity	26,180,694	24,746,882
Non-controlling Interest	25,000	25,000
Total equity	26,205,694	24,771,882
Total liabilities and stockholders' equity	$ 85,683,554	$ 87,150,859

About Joint Corp-The

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

CEO	Mr. Peter D. Holt
WEBSITE	thejoint.com
INDUSTRY	Healthcare Plans
EMPLOYEES	359

Joint Corp-The Frequently Asked Questions

What is the ticker symbol for Joint Corp-The? What does JYNT stand for in stocks?

JYNT is the stock ticker symbol of Joint Corp-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Joint Corp-The (JYNT)?

As of Fri May 17 2024, market cap of Joint Corp-The is 258.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of JYNT stock?

You can check JYNT's fair value in chart for subscribers.

What is the fair value of JYNT stock?

You can check JYNT's fair value in chart for subscribers. The fair value of Joint Corp-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Joint Corp-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for JYNT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Joint Corp-The a good stock to buy?

The fair value guage provides a quick view whether JYNT is over valued or under valued. Whether Joint Corp-The is cheap or expensive depends on the assumptions which impact Joint Corp-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for JYNT.

What is Joint Corp-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, JYNT's PE ratio (Price to Earnings) is -23.25 and Price to Sales (PS) ratio is 2.2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. JYNT PE ratio will change depending on the future growth rate expectations of investors.